November 11, 2026 · Heart rhythm · DOI: 10.1016/j.hrthm.2026.11.007

Anticoagulation in Subclinical Atrial Fibrillation: An Evidence-Based Framework for Individualized Management.

Listen to this summary

This review asks whether long-term anticoagulation is warranted for subclinical atrial fibrillation (SCAF), which is increasingly detected by wearables and cardiac implantable electronic devices. The authors argue that SCAF should be treated as a distinct entity on the spectrum of atrial disease, and they propose an individualized decision framework that weighs arrhythmia burden, baseline stroke risk, the degree of structural atrial cardiomyopathy, life expectancy, and patient preferences. The framework is built by synthesizing observational studies, randomized trials, and post-hoc analyses to guide risk-benefit decisions.

Anderson Ariaga, Farah Olleik, Peter R Kowey

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play